Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulmonx Corp LUNG

Healthcare Medical Devices
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX... see more

Recent & Breaking News (NDAQ:LUNG)

Pulmonx to Report First Quarter 2021 Financial Results on May 4, 2021

GlobeNewswire April 20, 2021

Pulmonx Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 2, 2021

Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021

GlobeNewswire February 16, 2021

JTV®, Pulmonx® Corporation & Respiratory Health Association® Launch 2021 Catch Your Breath® Campaign

PR Newswire January 28, 2021

Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth

GlobeNewswire December 8, 2020

Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD

GlobeNewswire November 30, 2020

Pulmonx Reports Third Quarter 2020 Financial Results

GlobeNewswire November 10, 2020

Pulmonx to Present at Upcoming Investor Conferences

GlobeNewswire November 3, 2020

Pulmonx Announces Additional 16 Million Covered Lives for The Zephyr® Valve, a Minimally Invasive Treatment Option for Severe Emphysema (COPD)

GlobeNewswire November 2, 2020

Pulmonx to Report Third Quarter 2020 Financial Results on November 10, 2020

GlobeNewswire October 22, 2020

Pulmonx Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewswire October 5, 2020

Pulmonx Corporation Announces Pricing of its Upsized Initial Public Offering

GlobeNewswire September 30, 2020